Eshmun Pharmacies Private Limited
Sells pharmaceutical, medical, cosmetic, and toilet products through retail stores.
2017 | Jammu, Jammu & Kashmir (India) | Active
Eshmun Pharmacies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.23 M
- Revenue Growth 13.11%
- Profit Growth 182.68%
- Ebitda 230.91%
- Net Worth 5.93%
- Total Assets 186.06%
About Eshmun Pharmacies
Eshmun Pharmacies Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 September 2017 (Seven years and five months 2 days old ). Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.23 M.
Nitish Mahajan and Ashwani Sharma serve as directors at the Company.
Company Details
- Location
Jammu, Jammu & Kashmir, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52609JK2017PTC010136
- Company No.
010136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
FMCG
Pharma
Who are the key members and board of directors at Eshmun Pharmacies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitish Mahajan  | Whole-Time Director | 26-Sep-2017 | Current |
| Ashwani Sharma | Whole-Time Director | 26-Sep-2017 | Current |
Financial Performance of Eshmun Pharmacies.
Eshmun Pharmacies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 13.11% increase. The company also saw a substantial improvement in profitability, with a 182.68% increase in profit. The company's net worth moved up by a moderate rise of 5.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eshmun Pharmacies?
In 2020, Eshmun Pharmacies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹8.23 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- The Jammu And Kashmir Bank Limited : 0.82 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2020 | The Jammu And Kashmir Bank Limited | ₹8.00 M | Open |
| 20 Jun 2020 | The Jammu And Kashmir Bank Limited | ₹0.23 M | Open |
How Many Employees Work at Eshmun Pharmacies?
Unlock and access historical data on people associated with Eshmun Pharmacies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eshmun Pharmacies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eshmun Pharmacies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.